Sodium Chloride + Dextrose interactions
Checked as Sodium chloride + Dextrose, unspecified form in this data source.
Full monograph for Sodium Chloride + DextroseCheck it against another medicine
Medicines
2 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Lithium Carbonatevia Sodium chloride | Moderate | Excretion | Large sodium intake may decrease serum lithium levels. Sodium restriction may increase lithium levels. The mechanism is increased renal excretion of lithium in… | 6 sources — open the full entry |
| Tolvaptanvia Sodium chloride | Moderate | Synergy | The use of tolvaptan with other treatments for hyponatremia or medications that increase serum sodium concentration may increase the risk of rapid correction… | 4 sources — open the full entry |
Conditions
Conditions in which Sodium Chloride + Dextrose needs care, as documented in this source.
Water-Electrolyte Imbalance
MajorSodium chloride can induce sodium and water retention and result in hypernatremia, hypokalemia, edema and aggravation of congestive heart failure. Therapy with sodium- containing agents should be administered with extreme caution, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states where there is edema with sodium retention. Clinical monitoring of acid/base balance and electrolytes prior to, during, a following completion of therapy with sodium- containing agents is recommended.
3 sources
- "Product Information. Megace (megestrol)." Bristol-Myers Squibb (2001):
- "Product Information. Calcibind (cellulose sodium phosphate)." Mission Pharmacal Company (2001):
- "Product Information. Sodium Benzoate (sodium benzoate)." Taylor Pharmaceuticals (2001):
Acidosis
ModerateAdministration of excessive amounts of sodium chloride can increase chloride concentrations and cause a loss of bicarbonate that results in metabolic acidosis. Clinical monitoring of acid/base balance and electrolyte concentrations is recommended.
1 source
- "Product Information. Megace (megestrol)." Bristol-Myers Squibb (2001):